Valproate	O
causes	O
birth	O
defects	O
;	O
exposure	O
during	O
pregnancy	O
is	O
associatedwith	O
about	O
three	NUMBER
times	O
as	O
many	O
major	O
abnormalities	O
as	O
usual	O
,	O
mainly	O
spinabifida	O
with	O
the	O
risks	O
being	O
related	O
to	O
the	O
strength	O
of	O
medication	O
used	O
and	O
useof	O
more	O
than	O
one	NUMBER
drug	O
.	O
More	O
rarely	O
,	O
with	O
several	O
other	O
defects	O
,	O
possibly	O
including	O
a	O
`	O
valproate	O
syndrome	O
'	O
.	O
Characteristics	O
of	O
thisvalproate	O
syndrome	O
include	O
facial	O
features	O
that	O
tend	O
to	O
evolve	O
with	O
age	O
,	O
including	O
a	O
triangle-shaped	O
forehead	O
,	O
tall	O
forehead	O
with	O
bifrontal	O
narrowing	O
,	O
epicanthic	O
folds	O
,	O
medial	O
deficiency	O
of	O
eyebrows	O
,	O
flat	O
nasal	O
bridge	O
,	O
broadnasal	O
root	O
,	O
anteverted	O
nares	O
,	O
shallow	O
philtrum	O
,	O
long	O
upper	O
lip	O
and	O
thinvermillion	O
borders	O
,	O
thick	O
lower	O
lip	O
and	O
small	O
downturned	O
mouth	O
.	O
Whiledevelopmental	O
delay	O
is	O
usually	O
associated	O
with	O
altered	O
physicalcharacteristics	O
,	O
this	O
is	O
not	O
always	O
the	O
case	O
.	O
